Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ellis

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
The Breast Journal|January 12, 2008
Implications of inconsistent measurement of ER status in non-invasive breast cancer: a study of 1,684 cases from the Sloane ProjectJeremy Thomas, Andrew Hanby, Sarah Pinder, et al.
Histopathology|May 9, 2021
Diagnostic concordance of phyllodes tumour of the breastEmad Rakha, Raluca Mihai, Areeg Abbas, et al.
Journal of Clinical Pathology|August 25, 2019
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situMichael Toss, Islam Miligy, Kylie Gorringe, et al.
European Journal of Human Genetics : EJHG|March 12, 2015
A prospective cohort study assessing clinical referral management & workforce allocation within a UK regional medical genetics serviceCaroline Benjamin, Catherine Houghton, Claire Foo, et al.
European Journal of Human Genetics : EJHG|July 17, 2015
A prospective cohort study assessing clinical referral management & workforce allocation within a UK regional medical genetics serviceCaroline Benjamin, Catherine Houghton, Claire Foo, et al.
Journal of Clinical Pathology|October 31, 2013
PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer womenAyodeji Agboola, Adewale Musa, Adekumbiola Banjo, et al.
Cancer Biology & Therapy|October 16, 2009
Elevated Src kinase activity attenuates Tamoxifen response in vitro and is associated with poor prognosis clinicallyLiam Morgan, Julia Gee, Sara Pumford, et al.
Cancer Immunity|October 24, 2007
Upregulation of MICA on high-grade invasive operable breast carcinomaZahra Madjd, Ian Spendlove, Robert Moss, et al.
Journal of Clinical Pathology|September 12, 2006
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.
Proteomics|September 16, 2003
A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditionsShahid Mian, Graham Ball, Jo Hornbuckle, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
The Breast Journal|January 12, 2008
Implications of inconsistent measurement of ER status in non-invasive breast cancer: a study of 1,684 cases from the Sloane ProjectJeremy Thomas, Andrew Hanby, Sarah Pinder, et al.
Histopathology|May 9, 2021
Diagnostic concordance of phyllodes tumour of the breastEmad Rakha, Raluca Mihai, Areeg Abbas, et al.
Journal of Clinical Pathology|August 25, 2019
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situMichael Toss, Islam Miligy, Kylie Gorringe, et al.
European Journal of Human Genetics : EJHG|March 12, 2015
A prospective cohort study assessing clinical referral management & workforce allocation within a UK regional medical genetics serviceCaroline Benjamin, Catherine Houghton, Claire Foo, et al.
European Journal of Human Genetics : EJHG|July 17, 2015
A prospective cohort study assessing clinical referral management & workforce allocation within a UK regional medical genetics serviceCaroline Benjamin, Catherine Houghton, Claire Foo, et al.
Journal of Clinical Pathology|October 31, 2013
PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer womenAyodeji Agboola, Adewale Musa, Adekumbiola Banjo, et al.
Cancer Biology & Therapy|October 16, 2009
Elevated Src kinase activity attenuates Tamoxifen response in vitro and is associated with poor prognosis clinicallyLiam Morgan, Julia Gee, Sara Pumford, et al.
Cancer Immunity|October 24, 2007
Upregulation of MICA on high-grade invasive operable breast carcinomaZahra Madjd, Ian Spendlove, Robert Moss, et al.
Journal of Clinical Pathology|September 12, 2006
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.
Proteomics|September 16, 2003
A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditionsShahid Mian, Graham Ball, Jo Hornbuckle, et al.
Pageof 10